{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:07:40Z","timestamp":1792184860965,"version":"4.4.0"},"reference-count":97,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2019,6,15]]},"abstract":"<jats:p>There is an increasing number of experimental, genetic and clinical evidence of atopic dermatitis expression as a pre-condition for later development of other atopic diseases such as asthma, food allergy and allergic rhinitis. Atopic dermatitis is a heterogeneous, recurrent childhood disease, also present in the adult age. It is increasingly attributed to systemic features and is characterized by immunological and skin barrier integrity and function dysregulation. To maintain the protective function of the skin barrier, in particular the maintenance of pH, hydration and antimicrobial functions, the filaggrin, among others, plays a significant role. Filaggrin is a multifunctional, histidine-rich, insoluble protein. The lack of filaggrin is associated with various cutaneous (e.g. ichthyosis vulgaris, allergic contact dermatitis) and non-cutaneous (e.g. diabetes, inflammatory conditions of the gastrointestinal tract) diseases and may be a result of genetic, immunological factors combined with environmental factors. In this review we summarised (emphasized) recent findings in understanding the role of filaggrin in atopic dermatitis and other diseases, participants in the atopic march.<\/jats:p>","DOI":"10.11613\/bm.2019.020501","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T08:29:55Z","timestamp":1559896195000},"page":"214-227","source":"Crossref","is-referenced-by-count":62,"title":["Filaggrin and atopic march"],"prefix":"10.11613","volume":"29","author":[{"given":"Ivana","family":"\u010cepelak","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3419-5171","authenticated-orcid":false,"given":"Slavica","family":"Dodig","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pavi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Allergology and Immunology, Children\u2019s Hospital Zagreb, Zagreb; School of Medicine University of Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4885","published-online":{"date-parts":[[2019,4,14]]},"reference":[{"key":"key20190607042953_r1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.8.3.163","article-title":"On the classification of the phenomena of hypersensitiveness.","volume":"8","author":"Coca","year":"1923","journal-title":"J Immunol"},{"key":"key20190607042953_r2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4168\/aair.2011.3.2.67","article-title":"The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma.","volume":"3","author":"Zheng","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"key20190607042953_r3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5195\/ijms.2014.100","article-title":"The atopic march. A Literature Review.","volume":"2","author":"Salazar- Espinoza JF","year":"2014","journal-title":"Int J Med Students."},{"key":"key20190607042953_r4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fped.2017.00044","article-title":"The nose and the lung: United airway disease?","volume":"5","author":"Licari","year":"2017","journal-title":"Front Pediatr"},{"key":"key20190607042953_r5","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.jaci.2003.09.033","article-title":"Atopic dermatitis and the atopic march.","volume":"112","author":"Spergel","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jaci.2017.04.004","article-title":"Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march.","volume":"139","author":"Czarnowicki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1398-9995.2008.01710.x","article-title":"Does a \u201ereverse\u201c atopic march exist?","volume":"63","author":"Barberio","year":"2008","journal-title":"Allergy"},{"key":"key20190607042953_r8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13671-015-0121-6","article-title":"Atopic dermatitis and respiratory allergy: What is the link.","volume":"4","author":"Belgrave","year":"2015","journal-title":"Curr Dermatol Rep"},{"key":"key20190607042953_r9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.12268","article-title":"Atopic dermatitis and the atopic march revisited.","volume":"69","author":"Dharmage","year":"2014","journal-title":"Allergy"},{"key":"key20190607042953_r10","first-page":"200","article-title":"Mutations in the filaggrin gene and food allergy.","volume":"9","author":"Ogrodowczyk","year":"2014","journal-title":"Prz Gastroenterol"},{"key":"key20190607042953_r11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anai.2017.10.037","article-title":"The atopic march. Critical evidence and clinical relevance.","volume":"120","author":"Hill","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20190607042953_r12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cea.13156","article-title":"New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: An overview.","volume":"48","author":"Amat","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"key20190607042953_r13","first-page":"901940","article-title":"Skin barrier function and its importance at the start of the atopic march.","volume":"2012","author":"Hogan","year":"2012","journal-title":"J Allergy (Cairo)"},{"key":"key20190607042953_r14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23312025.2015.1103459","article-title":"Pathogenesis of atopic dermatitis: A short review.","volume":"1","author":"Egawa","year":"2015","journal-title":"Cogent Biol"},{"key":"key20190607042953_r15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imr.12546","article-title":"The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.","volume":"278","author":"Han","year":"2017","journal-title":"Immunol Rev"},{"key":"key20190607042953_r16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5314\/wjd.v4.i1.16","article-title":"From the outside-in: Epidermal targeting as a paradigm for atopic disease therapy.","volume":"4","author":"Gillespie","year":"2015","journal-title":"World J Dermatol."},{"key":"key20190607042953_r17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2332\/allergolint.11-RAI-0376","article-title":"Cellular and molecular mechanisms of TSLP function in human allergic disorders - TSLP programs the \u201cTh2 code\u201d in dendritic cells.","volume":"61","author":"Ito","year":"2012","journal-title":"Allergol Int"},{"key":"key20190607042953_r18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1183\/09059180.00004314","article-title":"Current evidence of epidermal barrier dysfunction and tymic stromal lymphopoietin in the atopic march.","volume":"23","author":"Li","year":"2014","journal-title":"Eur Respir Rev"},{"key":"key20190607042953_r19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41598-017-00670-2","article-title":"TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents.","volume":"7","author":"Wallmeyer","year":"2017","journal-title":"Sci Rep"},{"key":"key20190607042953_r20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaci.2015.04.026","article-title":"Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinase (ERK) phosphorylation in keratinocytes.","volume":"136","author":"Kim","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.13228","article-title":"Is the atopic march related to confounding by genetics and early-life environment? A systemic review of sibship and twin data.","volume":"73","author":"Khan","year":"2018","journal-title":"Allergy"},{"key":"key20190607042953_r22","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1073\/pnas.78.7.4097","article-title":"Characterisation of a class of cationic proteins that specifically interact with intermediate filaments.","volume":"78","author":"Steinert","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20190607042953_r23","doi-asserted-by":"crossref","first-page":"24105","DOI":"10.1074\/jbc.271.39.24105","article-title":"Activator protein-1 activity is involved in the regulation of the cell-type specific expresion from the proximal promoter of human profilaggrin gene.","volume":"271","author":"Jang","year":"1996","journal-title":"J Biol Chem"},{"key":"key20190607042953_r24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1242\/jcs.106.1.219","article-title":"Identification of rat epidermal profilaggrin phosphatase as a member of the protein phosphatase 2A family.","volume":"106","author":"Kam","year":"1993","journal-title":"J Cell Sci"},{"key":"key20190607042953_r25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1242\/jcs.033969","article-title":"Filaggrin in the frontline: Role in skin barrier function and disease.","volume":"122","author":"Sandilands","year":"2009","journal-title":"J Cell Sci"},{"key":"key20190607042953_r26","first-page":"125","article-title":"Filaggrin \u2013 multifunctional protein.","volume":"70","author":"\u010cepelak","year":"2016","journal-title":"Acta Med Croatica"},{"key":"key20190607042953_r27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: Filaggrin.","volume":"132","author":"Brown","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key20190607042953_r28","doi-asserted-by":"crossref","first-page":"e98235","DOI":"10.1371\/journal.pone.0098235","article-title":"Filaggrin Gene Mutation c.332 delA is associated with various clinical features of atopic dermatitis in the Chinese han population.","volume":"9","author":"Meng","year":"2014","journal-title":"PLoS One"},{"key":"key20190607042953_r29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaci.2011.01.031","article-title":"Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy.","volume":"127","author":"Brown","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r30"},{"key":"key20190607042953_r31"},{"key":"key20190607042953_r32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic Dermatitis: Global epidemiology and risk factors.","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"key20190607042953_r33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2009.10.002","article-title":"From atopic dermatitis to asthma: the atopic march.","volume":"105","author":"Spergel","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20190607042953_r34","doi-asserted-by":"crossref","first-page":"923134","DOI":"10.1155\/2012\/923134","article-title":"Ben-Amital, Zvulunov A. Barrier-restoring therapies in atopic dermatitis: Current approaches and future perspectives.","volume":"2012","author":"Valdman-Grinshpoun","year":"2012","journal-title":"Dermatol Res Pract"},{"key":"key20190607042953_r35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41232-017-0044-7","article-title":"Kabashima. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.","volume":"37","author":"Rerknimitr","year":"2017","journal-title":"Inflamm Regen"},{"key":"key20190607042953_r36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1034\/j.1398-9995.2001.00144.x","article-title":"Epidemiology, clinical features, and immunology of the \u201cintrinsic\u201d (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis).","volume":"56","author":"Schmid\u2010Grendelmeier","year":"2001","journal-title":"Allergy"},{"key":"key20190607042953_r37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","article-title":"Increasing comorbidities suggest that atopic dermatitis is a systemic disorder.","volume":"137","author":"Brunner","year":"2017","journal-title":"J Invest Dermatol"},{"key":"key20190607042953_r38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1743","article-title":"Loss-of-function mutations in gene encoding filaggrin cause is ichthyosis vulgaris.","volume":"38","author":"Smith","year":"2006","journal-title":"Nat Genet"},{"key":"key20190607042953_r39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaci.2014.06.014","article-title":"Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.","volume":"134","author":"Thyssen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaci.2014.09.023","article-title":"The role of air pollutants in atopic dermatitis.","volume":"134","author":"Ahn","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.envres.2014.09.032","article-title":"The effect of phthalate exposure and filaggrin gene variants on atopic dermatitis.","volume":"136","author":"Wang","year":"2015","journal-title":"Environ Res"},{"key":"key20190607042953_r42","doi-asserted-by":"crossref","first-page":"e1656","DOI":"10.1038\/cddis.2015.29","article-title":"In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification.","volume":"6","author":"Pendaries","year":"2015","journal-title":"Cell Death Dis"},{"key":"key20190607042953_r43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2013.09.015","article-title":"Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects.","volume":"133","author":"Margolis","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2222.2004.01915.x","article-title":"SPINK5: a gene for atopic dermatitis and asthma.","volume":"34","author":"Moffatt","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"key20190607042953_r45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis.","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2009.11.008","article-title":"An update on genetics of atopic dermatitis: scratching the surface in 2009.","volume":"125","author":"Barnes","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r47","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ng.2739","article-title":"Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting.","volume":"45","author":"Samuelov","year":"2013","journal-title":"Nat Genet"},{"key":"key20190607042953_r48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13223-016-0158-5","article-title":"Genetic and epigenetic studies of atopic dermatitis.","volume":"12","author":"Bin","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"key20190607042953_r49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clindermatol.2013.11.007","article-title":"Atopic dermatitis as a systemic disease.","volume":"32","author":"Darlenski","year":"2014","journal-title":"Clin Dermatol"},{"key":"key20190607042953_r50","first-page":"24","article-title":"A review of the risk factors and clinical presentation of childhood atopic eczema at the primary healthcare level.","volume":"29","author":"Upton","year":"2016","journal-title":"Curr Allergy Clin Immunol"},{"key":"key20190607042953_r51","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/sj.jid.5701208","article-title":"Filaggrin expression in oral, nasal, and esophageal mucosa.","volume":"128","author":"De Benedetto","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key20190607042953_r52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13223-016-0137-x","article-title":"Filaggrin gene mutations and new SNP in asthmatic patients: a cross-sectional study in Spanish population.","volume":"12","author":"Cubero","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"key20190607042953_r53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2009.05.042","article-title":"Filaggrin-deficient mice exhibit Th17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen.","volume":"124","author":"Oyoshi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r54","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases.","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"key20190607042953_r55"},{"key":"key20190607042953_r56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"National Heart, Lung, and Blood Institute\u2019s Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key20190607042953_r57","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jaci.2010.02.011","article-title":"Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations.","volume":"125","author":"Holt","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/CRIAI:27:1:023","article-title":"ADAM 33 and its association with airway remodeling and hyperresponsiveness in asthma.","volume":"27","author":"Holgate","year":"2004","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20190607042953_r59","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1164\/rccm.2201081","article-title":"Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate.","volume":"165","author":"Deykin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key20190607042953_r60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of function variants of epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"key20190607042953_r61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/eci.11.100","article-title":"Filaggrin mutations and atopy: consequences for future therapeutics.","volume":"8","author":"Heimall","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"key20190607042953_r62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.10-RAI-0270","article-title":"Filaggrin gene defects and the risk of developing allergic disorders.","volume":"60","author":"Osawa","year":"2011","journal-title":"Allergol Int"},{"key":"key20190607042953_r63"},{"key":"key20190607042953_r64","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jaci.2006.07.026","article-title":"Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march.","volume":"118","author":"Marenholz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r65","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1399-3038.2010.01073.x","article-title":"Filaggrin gene variants and atopic diseases in early childhood assessed longitudinally from birth.","volume":"21","author":"B\u00f8nnelykke","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"key20190607042953_r66","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma.","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r67","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJM199109193251206","article-title":"Allergic rhinitis.","volume":"325","author":"Naclerio","year":"1991","journal-title":"N Engl J Med"},{"key":"key20190607042953_r68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5415\/apallergy.2011.1.3.157","article-title":"Overview on the pathomechanisms of allergic rhinitis.","volume":"1","author":"Pawankar","year":"2011","journal-title":"Asia Pac Allergy"},{"key":"key20190607042953_r69","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2003.1592","article-title":"Rhinitis and asthma: evidence for respiratory system integration.","volume":"111","author":"Togias","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r70","first-page":"B4278","article-title":"Upper and lower airway pathology in young children with allergic-and non-allergic rhinitis.","volume":"58","author":"Chawes","year":"2011","journal-title":"Dan Med Bull"},{"key":"key20190607042953_r71","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2008.02.014","article-title":"Filaggrin mutations, atopic eczema, hay fever, and asthma in children.","volume":"121","author":"Weidinger","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000365990","article-title":"Association of filaggrin variants with asthma and rhinitis: is eczema or allergic sensitization status an effect modifier?","volume":"164","author":"Ziyab","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"key20190607042953_r73","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2014.12.013","article-title":"Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.","volume":"135","author":"Kelleher","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r74"},{"key":"key20190607042953_r75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/000155500750042943","article-title":"Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children.","volume":"80","author":"Eberlein-K\u00f6nig","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"key20190607042953_r76","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1080\/00032719.2013.789881","article-title":"Evaluation of an HPLC method for the determination of natural moisturizing factors in the human stratum corneum.","volume":"46","author":"\u0110api\u0107","year":"2013","journal-title":"Anal Lett"},{"key":"key20190607042953_r77","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jaci.2012.01.068","article-title":"Altered stratum corneum barrier and enhanced percutaneous immune responses in fi laggrin-null mice.","volume":"129","author":"Kawasaki","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r78","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jid.2015.11.007","article-title":"Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and \u00df-defensins in filaggrin-deficient skin equivalents.","volume":"136","author":"H\u00f6nzke","year":"2016","journal-title":"J Invest Dermatol"},{"key":"key20190607042953_r79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jdermsci.2015.09.012","article-title":"Stimulation of PPAR\u03b1 normalizes the skin lipid ratio and improves the skin barrier of normal and filaggrin deficient reconstructed skin.","volume":"80","author":"Wallmeyer","year":"2015","journal-title":"J Dermatol Sci"},{"key":"key20190607042953_r80","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jaci.2015.04.042","article-title":"Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis.","volume":"136","author":"Riethmuller","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejpb.2008.11.013","article-title":"Non-invasive in vivo methods for investigation of the skin barrier physical properties.","volume":"72","author":"Darlenski","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"key20190607042953_r82","first-page":"431","article-title":"Early-life regional and temporal variation in filaggrin derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis.","volume":"179","author":"McAleer","year":"2018","journal-title":"Br J Dermatol"},{"key":"key20190607042953_r83","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression.","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0846.2010.00461.x","article-title":"Use of Raman spectroscopy in the early detection of filaggrin-related atopic dermatitis.","volume":"17","author":"Gonz\u00e1lez","year":"2011","journal-title":"Skin Res Technol"},{"key":"key20190607042953_r85","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2015.12.1306","article-title":"Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy.","volume":"137","author":"Kim","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r86","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1111\/j.1399-3038.2009.00919.x","article-title":"Increased serum thymic stromal lymphopoietin in children with atopic dermatitis.","volume":"21","author":"Lee","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"key20190607042953_r87","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1111\/ijd.12830","article-title":"Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.","volume":"54","author":"Gu","year":"2015","journal-title":"Int J Dermatol"},{"key":"key20190607042953_r88","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jaci.2017.08.024","article-title":"Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study.","volume":"141","author":"Tran","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2017.12.016","article-title":"Can the atopic march be predicted?","volume":"120","author":"Tran","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20190607042953_r90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2017.11.008","article-title":"An impaired epithelial barrier contributes to the atopic march.","volume":"120","author":"Johansson","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20190607042953_r91","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1365-2133.2002.04584.x","article-title":"Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin.","volume":"146","author":"Hoeger","year":"2002","journal-title":"Br J Dermatol"},{"key":"key20190607042953_r92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.anai.2017.11.023","article-title":"The skin as a target for prevention of the atopic march.","volume":"120","author":"Lowe","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key20190607042953_r93","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/jid.2013.506","article-title":"Crossing barriers; Restoring Barriers? Filaggrin Protein Replacement Takes a Bow.","volume":"134","author":"Irvine","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key20190607042953_r94","doi-asserted-by":"crossref","first-page":"923134","DOI":"10.1155\/2012\/923134","article-title":"Barrier-restoring therapies in atopic dermatitis: Current approaches and future perspectives.","volume":"2012","author":"Valdman-Grinshpoun","year":"2012","journal-title":"Dermatol Res Pract"},{"key":"key20190607042953_r95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/jid.2013.284","article-title":"Recombinant filaggrin is internalized and processed to correct filaggrin deficiency.","volume":"134","author":"Stout","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key20190607042953_r96","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaci.2013.07.027","article-title":"Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression.","volume":"133","author":"Otsuka","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"key20190607042953_r97","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jaip.2017.08.031","article-title":"Biologic therapy for atopic dermatitis: Moving beyond the practice parameter and guidelines.","volume":"5","author":"Boguniewicz","year":"2017","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/29\/2\/10.11613\/BM.2019.020501\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T08:07:12Z","timestamp":1694938032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/29\/2\/10.11613\/BM.2019.020501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,14]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,4,14]]},"published-print":{"date-parts":[[2019,6,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2019.020501","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,14]]}}}